Europe Molecular Diagnostics Market Is Expected To Reach USD 4.0 Billion By 2024: By Grand View Research, Inc.

The europe molecular diagnostics market is expected to reach USD4.0 billion by 2024, according to a new report by Grand View Research, Inc. Growing geriatric population and the increasing prevalence of neurological and cardiovascular disorders is expected to drive the growth of molecular diagnostics. Moreover, increasing demand for more efficient healthcare delivery to facilitate early diagnostics is further expected to boost market growth. 

Rising awareness levels among individuals pertaining to the availability of effective molecular diagnostic tests to determine the presence of genetic disorders is expected to increase the client base for this industry, consequently leading to early diagnosis of disorders in the population. 

In addition, with the demand for high levels of accuracy and cost effectiveness of diagnostic procedures, the existent technologies are continually undergoing progressive changes to develop improved and efficient testing tools. Presence of a number of established healthcare facilities coupled with the technological advancements facilitating and expediting accurate disease diagnosis are expected to serve this market as significant drivers fueling growth. 

Europe Molecular Diagnostics Market, by application, 2013 - 2024 (USD Million)



Browse full research report on Europe Molecular Diagnostics Market: http://www.grandviewresearch.com/industry-analysis/europe-molecular-diagnostics-market

Further key findings from the report suggest:

  • The overall vertical was dominated by the reagents with their revenue generation estimated at over USD 930.0 million in 2015 owing to their higher usage including formamide, salts, and dextran sulphate or heparin employed in the drug development process to detect disease-related novel biomarkers
  • Introduction of reagents for technologically advanced instruments are anticipated to attribute towards an attractive growth of reagents segment over the forecast period
  • Central laboratories held the largest market share of around 60% in 2015 owing to the highly developed healthcare infrastructure and skilled healthcare professionals & staff associated with them.
  • Point of care is the fastest growing test location segment with an estimated CAGR of over 12.0% over the forecast period. Increasing demand for expedited diagnosis and rapid analysis has led to the growth of this section.
  • Infectious diseases dominated the market on the basis of application with the largest revenue contribution in 2015 owing to the large test volumes and extensive portfolio of commercialized products in this area.
  • HIV held the largest market share of around 14.0% in 2015 in the infectious disease segment. Government initiatives being undertaken in Italy and France to create higher awareness about infectious diseases, such as HIV/AIDS and Hepatitis B, are factors responsible for its high market share.
  • Polymerase chain reaction (PCR) technology dominated the vertical with overall market revenue of over USD 725.0 million, attributable to the increasing application of molecular diagnostics in the field of drug discovery & development and pharmacogenomics
  • DNA sequencing is estimated to emerge as a profitable market over the forecast period with a CAGR of around 15.0%. With the sweeping technological advancements in the field, DNA sequencing is presently one of the most cost-effective technologies used to decode the genetic cause underlying a range of diseases.
  • The next generation sequencing technology segment will witness the highest growth rate throughout the forecast period majorly owing to the increasing R&D initiatives for development of novel drugs.
  • Germany held the largest market share with maximum revenue generation in 2015, which is attributed primarily to its huge elderly population base. Growing geriatric population coupled with decreased immune levels would engender the widespread prevalence of chronic diseases conditions comprising cardiovascular, neurological, and diabetes
  • The molecular diagnostics sector in the UK is estimated to grow at a faster rate with a CAGR of over 11.0% throughout the forecast period. The presence of sophisticated healthcare infrastructure, higher disposable income, and the increasing R&D intensity are the key factors contributing towards the growth of this sector in the UK.
  • Some leading companies in the molecular diagnostics sector include Roche Diagnostics, Alere Inc., Cepheid, Hologic, Inc. (Gen Probe), Sysmex Corporation, Abbott Laboratories, Bayer AG, Siemens Healthcare GmbH, Becton, Dickinson and Company, Johnson & Johnson, bioMérieux SA, Dako, Novartis AG (Grifols), Danaher Corporation, Bio-Rad Laboratories, Inc., and Qiagen N.V.
  • The established players in this vertical are adopting strategies, such as mergers and acquisitions, new product development, expansion activities pertaining to R&D of novel diagnostic products, and strategic collaborations to widen their existent product portfolios 
Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/europe-molecular-diagnostics-market-analysis  
                      
About Grand View Research, Inc:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information: http://www.grandviewresearch.com


Comments

Post a Comment

Popular posts from this blog

The global vein illuminator market is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future. The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is further categorized into transillumination, infrared technology, and ultrasound. The near-infrared illumination technology is estimated to be the largest shareholder due to its ability to penetrate deep into the tissue, which makes it possible to visualize the vessels clearly. On the basis of application, the market is segmented into intravenous access and blood draw. The end-user segment comprises hospitals, rehabilitation facilities, blood donation camps, and academic institutions. The market for hospitals is expected to grow rapidly during the forecast period due to a surge in the demand for technologically advanced medical equipment. The market is also categorized into North America, Europe, Asia Pacific, MEA, and Latin America. Browse full research report on global Vein Illuminator Market: http://www.grandviewresearch.com/industry-analysis/vein-illuminator-market Further key findings from the study suggest: • In terms of market share, the North America vein illuminator market is expected to hold majority of the share in 2016. Factors resulting in the growth of this industry are the steady preference for highly-advanced medical devices by hospitals as well as the presence of several medical device manufacturing companies in the region. • The infrared illumination technology is estimated to lead the industry due to its deep penetration capability into thick tissues tohighlight the presence of vessels with increased clarity. Based on application, the segment for intravenous access is estimated to be the largest shareholder, followed by the blood draw segment. • The vein illuminator industry comprises several local as well as global players. Some prominent players in this industry include Accuvein, Inc., Christie Medical Holdings, Inc., Infrared Imaging Systems, Inc., Translite, LLC, and Venoscope, LLC,among others. In order to hold a major share in the industry, the companies are adopting both organic as well as inorganic strategies. The major strategies adopted by the companies are new product development, mergers, collaborations, partnerships, geographical expansions, and acquisitions. • The companies are also focusing on research and development activities in order to enhance their product portfolio. For instance, in September 2015, Accuvein, Inc., declared its 26th patent, which was issued by the United States Patent and Trademark office for their vein visualization system. Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices Grand View Research has segmented the vein illuminator market on the basis of technology, application, and end-user application: Vein Illuminator Technology Outlook (Revenue, USD Million, 2013 - 2024) • Transillumination • Infrared technology • Others Vein Illuminator Application Outlook (Revenue, USD Million, 2013 - 2024) • Intravenous access • Blood draw • Others Vein Illuminator End-user Outlook (Revenue, USD Million, 2013 - 2024) • Hospitals • Blood donation camps • Academic institutions • Others Vein Illuminator Regional Outlook (Revenue, USD Million, 2013 - 2024) • North America • Europe • Asia Pacific • Latin America • MEA Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-vein-illuminator-market About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc For more information: www.grandviewresearch.com

The global  vein illuminator market  is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future. The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is further categorized into transillumination, infrared technology, a...
Read more

Hyaluronic Acid Market Is Likely To Be Influenced By The Increase In Obesity Till 2024: Grand View Research, Inc.

Image
The global  hyaluronic acid market   is expected to reach USD 13.4 billion by 2024, according to a new report by Grand View Research. Factors such as increasing concern in population regarding chemicals, desire to get quick and evident results, and shorter recovery time are high impact-rendering drivers of this market.  The market is evolving rapidly due to the increasing adoption of aesthetic procedures in both developed and developing regions. The growing geriatric population coupled with growing awareness about antiaging products and aspiration to look healthy and young is fueling the market for all cosmetics. The efficacy and evident results of hyaluronic acid - based dermal fillers are attracting this population base.  The increase in obesity resulting in osteoarthritis and joint pain has boosted the demand for hyaluronic acid injections as treatment. In 2012, approximately 53 million people were diagnosed with osteoarthritis and it is projected that b...
Read more

Protein Purification & Isolation Market Is Predicted To Grow Swiftly Due To Increased Research In The Fields Of Biotechnology & Pharmaceuticals Till 2025: Grand View Research, Inc.

Image
The global  protein purification and isolation market  is expected to be USD 9.5 billion by 2025, based on a new report by Grand View Research, Inc. Increased funding from both public and private research organizations for research and development of structure-based drugs and technological advancements are key drivers for the market.  Demand is increasing for the development of protein purification products based on single use purification process owing to increased proteomics research and rising need to identify new protein-based ligands with high specificity. Availability of a wide range of novel resins specific for different end users is estimated to be one of the drivers increasing the adoption rate of protein purification techniques. U.S. protein purification & isolation market, by technology, 2014 - 2025 (USD Billion) Browse full research report on Protein Purification & Isolation Market: http://www.grandviewresearch.com/industry-analysi...
Read more